Abstract. Schistosomiasis prevalence data for Nigeria were extracted from peer-reviewed journals and reports, geo-referenced and collated in a nationwide geographical information system database for the generation of point prevalence maps. This exercise revealed that the disease is endemic in 35 of the country's 36 states, including the federal capital territory of Abuja, and found in 462 unique locations out of 833 different survey locations. Schistosoma haematobium, the predominant species in Nigeria, was found in 368 locations (79.8%) covering 31 states, S. mansoni in 78 (16.7%) locations in 22 states and S. intercalatum in 17 (3.7%) locations in two states. S. haematobium and S. mansoni were found to be co-endemic in 22 states, while co-occurrence of all three species was only seen in one state (Rivers). The average prevalence for each species at each survey location varied between 0.5% and 100% for S. haematobium, 0.2% to 87% for S. mansoni and 1% to 10% for S. intercalatum. The estimated prevalence of S. haematobium, based on Bayesian geospatial predictive modelling with a set of bioclimatic variables, ranged from 0.2% to 75% with a mean prevalence of 23% for the country as a whole (95% confidence interval (CI): 22.8-23.1%). The model suggests that the mean temperature, annual precipitation and soil acidity significantly influence the spatial distribution. Prevalence estimates, adjusted for school-aged children in 2010, showed that the prevalence is <10% in most states with a few reaching as high as 50%. It was estimated that 11.3 million children require praziquantel annually (95% CI: 10.3-12.2 million).
SummarySchistosomiasis is a public health problem in Nigeria. Although there is a national programme for its control, there is the need for reliable and simple means of rapidly diagnosing communities to provide a detailed map on the distribution of the disease in the country, in order to prioritize control activities, as well as to monitor the effectiveness of control operations. A rapid assessment technique using school questionnaires was tested in Borgu Local Government Area (LGA), Niger State, north-western Nigeria. Following a series of focus group discussions, the questionnaires were adapted before they were administered through the school system to 60 primary schools in Borgu LGA. Correctly completed questionnaires were returned from 58 schools (97%) within 4 weeks. Questionnaires were validated by reagent stick tests performed by trained teachers. Their results proved to be reliable compared to those obtained by our research team in 20 randomly selected schools. Overall prevalences of microhaematuria at 1ϩ and 2ϩ levels were 45.7% and 27.1%, respectively. Highly significant correlations were obtained between school prevalence of microhaematuria and reported schistosomiasis, as well as reported blood in urine. The diagnostic performance of the questionnaires at the 2ϩ level of microhaematuria was very good. The design of our study also allowed data analysis on an individual level, and multivariate analysis revealed highly significant odds ratios for reported schistosomiasis and reported blood in urine to detect an individual with urinary schistosomiasis. Our results are in good agreement with reports from other African countries, and questionnaires can be recommended for rapid identification of communities at highest risk of urinary schistosomiasis in Nigeria, so that scarce resources of the national control programme can be used most effectively.keywords Nigeria, questionnaires, rapid assessment technique, Schistosoma haematobium, urinary schistosomiasis correspondence M. A. Mafe, Schistosomiasis Workgroup Borgu (SCHWOB),
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.